Authors: BROERS A HENZENLOGMANS S KUENENBOUMEESTER V DELARIVIERE GB VANDERHOLT B LOWENBERG B CORNELISSEN JJ

Citation: A. Broers et al., TRANSPLANT-RELATED MORTALITY FOLLOWING ALLOGENEIC BMT IN CMV SEROPOSITIVE DONOR RECIPIENT PAIRS IS INCREASED DESPITE EFFICACIOUS PREVENTIONOF CMV DISEASE BY PREEMPTIVE THERAPY WITH GANCICLOVIR/, British Journal of Haematology, 102(1), 1998, pp. 13-13

Authors: NOOTER K DELARIVIERE GB KLIJN J STOTER G FOEKENS J

Citation: K. Nooter et al., MULTIDRUG-RESISTANCE PROTEIN IN RECURRENT BREAST-CANCER, Lancet, 349(9069), 1997, pp. 1885-1886

Authors: NOOTER K DELARIVIERE GB LOOK MP VANWINGERDEN KE HENZENLOGMANS SC SCHEPER RJ FLENS MJ KLIJN JGM STOTER G FOEKENS JA

Citation: K. Nooter et al., THE PROGNOSTIC-SIGNIFICANCE OF EXPRESSION OF THE MULTIDRUG-RESISTANCEASSOCIATED PROTEIN (MRP) IN PRIMARY BREAST-CANCER, British Journal of Cancer, 76(4), 1997, pp. 486-493

Authors: DIKKESCHEI LD WOLTHERS BG BOSZUUR I DELARIVIERE GB NAGEL GT VANDERKOLK DA WILLEMSE PHB

Citation: Ld. Dikkeschei et al., OPTIMIZATION OF A CLASSICAL AROMATASE-ACTIVITY ASSAY AND APPLICATION IN NORMAL, ADENOMATOUS AND MALIGNANT BREAST PARENCHYMA, Journal of steroid biochemistry and molecular biology, 59(3-4), 1996, pp. 305-313

Authors: VANDENBERG E DIJKHUIZEN T STORKEL S DELARIVIERE GB DAM A MENSINK HJA OOSTERHUIS JW DEJONG B

Citation: E. Vandenberg et al., CHROMOSOMAL CHANGES IN RENAL ONCOCYTOMAS - EVIDENCE THAT T(5-11)(Q35-Q13) MAY CHARACTERIZE A 2ND SUBGROUP OF ONCOCYTOMAS, Cancer genetics and cytogenetics, 79(2), 1995, pp. 164-168